Studies have also demonstrated that serum CXCL8 levels can significantly predict GC risk and reveal a role of the CXCL8/CXCR2 axis and inflammation in the pathogenesis of this malignancy [70]. This evidence concerns the gene CXCR2 and gastric cancer.